#GUTAbstract by Mao et al on
"Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study" via https://t.co/uA32k1nwpr
Paper: https://t.co/vpBwqtmcvM
@WK_Seto@CheungKaShingM2@hkumed@HKUniversity
A BIG thanks to this panel of esteemed leaders of our global liver community for drawing attention to the threat of #MAFLD and helping to save lives.
Your enthusiasm and support mean the world to us. ❤️
✅ Join our mission: ➡️ A world in which no one suffers from the consequences of #MAFLD 🌎🌍🌏
#livertwitter #medtwitter
Prevalence of H pylori is decreasing but still affect >40% of the world population. Concerted efforts are needed to further combat the infection and its complications. @kathysleung@hkumed
Can managing hepatitis B be like diabetes? "Shared-care" between primary & specialty care?
It works! Has better coverage! & cost-effective!
Read the article in @LancetRH_WPac
https://t.co/3rSdbkSOAf
Thanks to @Prof_Lei_Zhang , William Wong, @DrJasonJOng and many others
@hkumed
Old-style academic output! Never thought I would be editing an academic book....well here is the first edition! My sincere thanks to my fantastically efficient co-editor Prof Mohammed Eslam of @Sydney_Uni and to the many many contributors!
#hepatitis#liver@hkumed
It is my great honour to present the work of our group in #TLM2022 organized by the #AASLD. Learned so much from this meeting and proud of our team #hkumed I treasure the opportunity to physically meet my good friends and experts in the field.
We should aim for better glycemic control among people living with both chronic hepatitis B and type 2 DM. See editorial: https://t.co/BCaFHnfHb3 @HEP_Journal @WK_Seto @DavidLui_HKU @jamesyyfung @hkumed https://t.co/TtUYNH0OSt
If a patient with chronic hepatitis B achieves functional cure, there is a biomarker that predicts the uncommon occurrence of liver cancer.
Published in Clinical Infectious Diseases. @CIDJournal
https://t.co/V3IMu4wciL
#hbv#fibrosis@loeymak@RexWHHui@jamesyyfung@hkumed
Novel magnetic resonance metrics for newly-diagnosed liver cancer.
Collaboration between Medicine, Surgery, Radiology and Pathology; @hkumed & HK Sanatorium.
#livercancer#mri#fibrosis#fattyliver#hepatitis
Read the article at https://t.co/Nn2IWTCNsH
New Research: Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction https://t.co/vQBYMr3u4Z #microbiology
'Review: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data'
#HBV#tenofovir_alafenamide#hepatology
READ FREE OPEN ACCESS at https://t.co/8mXl6BfAqC
🆕Article in press❕
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on #HBV genotype and viral antigen levels
#OpenAcces at👉https://t.co/KeYIO1LRqc
#LiverTwitter
We are excited to share our new findings on the neutralization of omicron variant by pediatric vaccine recipient and convalescent sera. https://t.co/PbMgX417p8
@tandfonline@hkumed